New treatment option for metastatic colorectal cancer prolongs survival

preview_player
Показать описание
#colorectalcancer #treatment #FRESCO-2

A new therapy is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options.
Results from an international clinical trial, published June 15 in The Lancet, show that the selective targeted therapy,  Fruquintinib, resulted in a statistically significant improvement in overall survival and
progression-free survival.

Follow us on
Рекомендации по теме